Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatesh Pilla-Reddy

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Biopharmaceutics & Drug Disposition|April 21, 2021
Special issue on applications of modeling and simulation in pharmaceutical drug developmentVenkatesh Pilla Reddy
Biopharmaceutics & Drug Disposition|March 24, 2021
Blood retinal barrier and ocular pharmacokinetics: Considerations for the development of oncology drugsBeth Williamson, Venkatesh Pilla Reddy
British Journal of Clinical Pharmacology|March 18, 2021
Food constituent- and herb-drug interactions in oncology: Influence of quantitative modelling on Drug labellingVenkatesh Pilla Reddy, Heeseung Jo, Sibylle Neuhoff
Fundamental & Clinical Pharmacology|November 16, 2023
Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitationsMonika Berezowska, Pradeep Sharma, Venkatesh Pilla Reddy, et al.
Pharmaceutics|May 27, 2023
Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric PopulationAndrew Lim, Pradeep Sharma, Oleg Stepanov, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 23, 2018
Development, Verification, and Prediction of Osimertinib Drug-Drug Interactions Using PBPK Modeling Approach to Inform Drug LabelVenkatesh Pilla Reddy, Michael Walker, Pradeep Sharma, et al.
Clinical Pharmacology and Therapeutics|May 3, 2018
Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient PopulationsVenkatesh Pilla Reddy, Khanh Bui, Graeme Scarfe, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 3, 2021
Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P-glycoprotein-cytochrome P450 3A4 dual substratesXian Pan, Shinji Yamazaki, Sibylle Neuhoff, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 29, 2017
In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450Alex McCormick, Helen Swaisland, Venkatesh Pilla Reddy, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 13, 2021
Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental ChangesHeeseung Jo, Venkatesh Pilla Reddy, Joanna Parkinson, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Biopharmaceutics & Drug Disposition|April 21, 2021
Special issue on applications of modeling and simulation in pharmaceutical drug developmentVenkatesh Pilla Reddy
Biopharmaceutics & Drug Disposition|March 24, 2021
Blood retinal barrier and ocular pharmacokinetics: Considerations for the development of oncology drugsBeth Williamson, Venkatesh Pilla Reddy
British Journal of Clinical Pharmacology|March 18, 2021
Food constituent- and herb-drug interactions in oncology: Influence of quantitative modelling on Drug labellingVenkatesh Pilla Reddy, Heeseung Jo, Sibylle Neuhoff
Fundamental & Clinical Pharmacology|November 16, 2023
Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitationsMonika Berezowska, Pradeep Sharma, Venkatesh Pilla Reddy, et al.
Pharmaceutics|May 27, 2023
Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric PopulationAndrew Lim, Pradeep Sharma, Oleg Stepanov, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 23, 2018
Development, Verification, and Prediction of Osimertinib Drug-Drug Interactions Using PBPK Modeling Approach to Inform Drug LabelVenkatesh Pilla Reddy, Michael Walker, Pradeep Sharma, et al.
Clinical Pharmacology and Therapeutics|May 3, 2018
Physiologically Based Pharmacokinetic Modeling for Olaparib Dosing Recommendations: Bridging Formulations, Drug Interactions, and Patient PopulationsVenkatesh Pilla Reddy, Khanh Bui, Graeme Scarfe, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 3, 2021
Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P-glycoprotein-cytochrome P450 3A4 dual substratesXian Pan, Shinji Yamazaki, Sibylle Neuhoff, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|June 29, 2017
In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450Alex McCormick, Helen Swaisland, Venkatesh Pilla Reddy, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 13, 2021
Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental ChangesHeeseung Jo, Venkatesh Pilla Reddy, Joanna Parkinson, et al.
Pageof 6